These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3177963)

  • 1. Occult thyrotoxicosis in patients with atrial fibrillation and an acute arterial embolism.
    Monreal M; Lafoz E; Foz M; Sanmarti A; Salinas I; Audi L; Viver E
    Angiology; 1988 Nov; 39(11):981-5. PubMed ID: 3177963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occult thyrotoxicosis: a correctable cause of "idiopathic" atrial fibrillation.
    Forfar JC; Miller HC; Toft AD
    Am J Cardiol; 1979 Jul; 44(1):9-12. PubMed ID: 110126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic algorithm for atrial fibrillation caused by occult hyperthyroidism.
    Sulimani RA
    Geriatrics; 1989 Nov; 44(11):61-4, 69. PubMed ID: 2509297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities in pituitary thyroid axis function tests in patients with paroxysmal supraventricular arrhythmias.
    Vermiglio F; Benvenga S; Granata A; Sobbrio G; Melluso C; Carerj S; Arrigo F; Consolo F; Trimarchi F
    Horm Metab Res; 1987 Feb; 19(2):71-5. PubMed ID: 3104185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult thyrotoxicosis in patients with chronic and paroxysmal isolated atrial fibrillation.
    Ciaccheri M; Cecchi F; Arcangeli C; Dolara A; Zuppiroli A; Pieroni C
    Clin Cardiol; 1984 Jul; 7(7):413-6. PubMed ID: 6744697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of thyrotrophin releasing hormone tests in elderly patients with atrial fibrillation.
    Davies AB; Williams I; John R; Hall R; Scanlon MF
    Br Med J (Clin Res Ed); 1985 Sep; 291(6498):773-6. PubMed ID: 3929935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systematic ultrasensitive determination of thyroid-stimulating hormone in 50 cases of atrial fibrillation].
    Schlienger JL; Cherfan J; Drawin T; Sacrez A
    Presse Med; 1988 Apr; 17(16):787-90. PubMed ID: 2968566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is idiopathic atrial fibrillation caused by occult thyrotoxicosis? A study of one hundred consecutive patients with atrial fibrillation.
    Giladi M; Aderka D; Zeligman-Melatzki L; Finkelstein A; Ayalon D; Levo Y
    Int J Cardiol; 1991 Mar; 30(3):309-13. PubMed ID: 1905273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embolism in thyrotoxic atrial fibrillation.
    Yuen RW; Gutteridge DH; Thompson PL; Robinson JS
    Med J Aust; 1979 Jun; 1(13):630-1. PubMed ID: 492021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial embolism in thyrotoxicosis with atrial fibrillation.
    Staffurth JS; Gibberd MC; Fui SN
    Br Med J; 1977 Sep; 2(6088):688-90. PubMed ID: 902055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide and cyclic guanosine monophosphate plasma concentrations in patients with thyrotoxicosis and atrial fibrillation. Effect of short-term methimazole therapy.
    Czekalski S; Widecka K; Gozdzik J; Ciechanowski K; Krzyzanowska-Swiniarska B; Gromniak E; Gruszczynska M
    J Endocrinol Invest; 1994 May; 17(5):341-6. PubMed ID: 8077618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of responsiveness to thyrotropin-releasing hormone and thyroid suppressibility following antithyroid drug therapy of hyperthyroidism.
    Martino E; Pinchera A; Capiferri R; Macchia E; Sardano G; Bartalena L; Mazzanti F; Baschieri L
    J Clin Endocrinol Metab; 1976 Sep; 43(3):543-9. PubMed ID: 821960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why are the sensitive TSH assay and TRH stimulation test frequently low in very old euthyroid subjects?
    Caradoc-Davies TH; Loan P; Campbell AJ
    N Z Med J; 1988 Oct; 101(856 Pt 1):662-3. PubMed ID: 3141851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRH testing, T4-thyrotoxicosis and the aging thyroid gland.
    Croxson MS; Wilson TM; Ballantyne GH
    N Z Med J; 1981 Jun; 93(686):417-20. PubMed ID: 6789262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardio-thyrotoxicosis with arrhythmia disclosed by an embolic cerebrovascular accident].
    Caroff P; Paris A; Genco G; Le Guern G; Dumas P
    Ann Fr Anesth Reanim; 1996; 15(2):196-8. PubMed ID: 8734241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is a more active attitude warranted in patients with subclinical thyrotoxicosis?
    Tenerz A; Forberg R; Jansson R
    J Intern Med; 1990 Sep; 228(3):229-33. PubMed ID: 2401873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
    Kaplan MM; Taft JA; Reichlin S; Munsat TL
    J Clin Endocrinol Metab; 1986 Oct; 63(4):808-14. PubMed ID: 3091628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Embolic episodes after treatment of atrial fibrillation in a patient with thyrotoxicosis].
    Hendriksen O; Petersen CL
    Ugeskr Laeger; 1995 Jul; 157(29):4138-9. PubMed ID: 7652995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Masked thyroid dysfunction among elderly patients with atrial fibrillation.
    Tajiri J; Hamasaki S; Shimada T; Morita M; Higashi K; Ohishi S; Sato T
    Jpn Heart J; 1986 Mar; 27(2):183-90. PubMed ID: 3723796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.